Favorable binding of quercetin to α-synuclein as potential target in Parkinson disease: an insilico approach
HS Baul, M Rajiniraja - Research Journal of Pharmacy and …, 2018 - indianjournals.com
The aim of the research is to identify possible flavonoid for the effective docking into α-
Synuclein in Parkinson's disease (PD) computationally. Flavonoids are evolving as the
potential cure for the PD. α-Synuclein is one of the potential drug target involving in the
death of dopaminergic neurons of Substantia Nigra Pars Compacta (SNPC) of basal ganglia
in PD. In our study, molecular docking analysis were carried out on flavonoids like quercetin,
epigallocatechin gallate (EGCG) and acacetin to investigate their inhibitory role and binding …
Synuclein in Parkinson's disease (PD) computationally. Flavonoids are evolving as the
potential cure for the PD. α-Synuclein is one of the potential drug target involving in the
death of dopaminergic neurons of Substantia Nigra Pars Compacta (SNPC) of basal ganglia
in PD. In our study, molecular docking analysis were carried out on flavonoids like quercetin,
epigallocatechin gallate (EGCG) and acacetin to investigate their inhibitory role and binding …
[PDF][PDF] Favorable binding of Quercetin to α-Synuclein as potential target in Parkinson disease: An Insilico approach
R Muniyan - researchgate.net
The aim of the research is to identify possible flavonoid for the effective docking into α-
Synuclein in Parkinson's disease (PD) computationally. Flavonoids are evolving as the
potential cure for the PD. α-Synuclein is one of the potential drug target involving in the
death of dopaminergic neurons of Substantia Nigra Pars Compacta (SNPC) of basal ganglia
in PD. In our study, molecular docking analysis were carried out on flavonoids like quercetin,
epigallocatechin gallate (EGCG) and acacetin to investigate their inhibitory role and binding …
Synuclein in Parkinson's disease (PD) computationally. Flavonoids are evolving as the
potential cure for the PD. α-Synuclein is one of the potential drug target involving in the
death of dopaminergic neurons of Substantia Nigra Pars Compacta (SNPC) of basal ganglia
in PD. In our study, molecular docking analysis were carried out on flavonoids like quercetin,
epigallocatechin gallate (EGCG) and acacetin to investigate their inhibitory role and binding …
以上显示的是最相近的搜索结果。 查看全部搜索结果